Akèy › Skleroz Miltip › Alabama
Etid klinik pou Skleroz Miltip nan Alabama
8 etid pou Skleroz Miltip ap chèche patisipan nan sit nan Alabama.
Vil nan Alabama
Tèks ofisyèl etid la (Anglè)
Understanding the Impact of Meal Timing on Neurological Health in Adults With Multiple Sclerosis
- University of Alabama at Birmingham, Birmingham
Ap rekrite
Laj 18 a 64 · Tout sèks · Mizajou Sep 25, 2026 · NCT07475377A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Birmingham
- TG Therapeutics Investigational Trial Site, Cullman
- TG Therapeutics Investigational Trial Site, Huntsville
- ak 1 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- North Central Neurology Associates- Site Number : 8401100, Cullman
- Alabama Neurology Associates- Site Number : 8400115, Homewood
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT07325292A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Alabama Neurology Associates, Birmingham
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06782490A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Alabama Neurology Associates PC, Birmingham
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
- University of Alabama at Birmingham Medical Center, Birmingham
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 65 · Tout sèks · Mizajou Jun 2, 2026 · NCT03759522Care in Multiple Sclerosis (MS)
- University of Alabama at Birmingham, Birmingham
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 5, 2026 · NCT07011914Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.